Apollomics, Inc.

NASDAQ:APLM

Biotechnology

Healthcare
$17.84 +34.72%

+$6.03 today

Market cap
$52.00M
Beta
1.45
P/E (TTM)
-3.1
EPS (TTM)
-$25.98
52W Low $3.66High $42.12

Volume 0.02M

Average 0.02M

Balance Sheet

Inspect the capital base behind the business.

Assets

$6.71M

FY 2025 · Annual

-48.7% YoY

Liabilities

$9.90M

FY 2025 · Annual

+20.3% YoY

Equity

-$3.19M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents46.74M32.68M32.06M9.77M3.28M
Short-term Investments47.74M21.94M5.76M00
Net Receivables506K547K466K127K2.49M
Inventory2.26M0000
Other Current Assets120K07K00
Total Current Assets99.37M55.79M39.93M10.27M6.05M
Property, Plant & Equipment (Net)1.32M1.48M586K1.02M580K
Goodwill00000
Intangible Assets14.8M14.78M14.76M1.74M0
Long-term Investments7.84M4.31M000
Tax Assets00000
Other Non-current Assets113K124K119K75K83K
Total Non-current Assets24.07M20.69M15.46M2.83M663K
Total Assets123.44M76.48M55.39M13.1M6.71M
Account Payables00000
Short-term Debt2.16M04.24M00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities(508K)68K000
Total Current Liabilities13.56M12.36M13.56M7.4M6.33M
Long-term Debt322.22M0000
Deferred Tax Liabilities(3.62M)0000
Deferred Revenue (Non-current)3.62M0000
Other Non-current Liabilities322.22M511.86M330K102K3.14M
Total Non-current Liabilities322.74M512.24M597K835K3.58M
Total Liabilities336.3M524.6M14.15M8.23M9.9M
Common Stock40K41K9K11K21K
Retained Earnings(235.44M)(474.6M)(646.97M)(700.82M)(711.76M)
Accumulated OCI12.29M3.4M26.72M3.44M3.44M
Other Stockholders Equity010.83M035.71M34.73M
Minority Interest00000
Total Equity(212.86M)(448.12M)41.23M4.86M(3.19M)
Total Debt325.41M991K4.66M966K643K
Net Debt278.67M(31.68M)(27.4M)(8.8M)(2.63M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$3.3M
Receivables$2.5M
Other Current$285.0K
Total Current Assets$6.1M
PP&E (Net)$580.0K
Other Non-current$83.0K
Total Non-current Assets$663.0K
Total Assets$6.7M

Analysis

Selected assets total $6.7M for Latest. The largest visible component is Cash & Equivalents at $3.3M, about 48.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
4/A4/A filingSep 24, 2026
4/A4/A filingSep 24, 2026
4/A4/A filingSep 24, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

How much cash does APLM have?

Apollomics, Inc. (APLM) reported $3.28M in cash and equivalents in fiscal 2025.

How much debt does APLM carry?

Apollomics, Inc. (APLM) reported $643,000.00 of total debt, with net debt of -$2.63M.